Recombinant Hemiechinus auritus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Hemiechinus auritus MT-ND4L

Recombinant Hemiechinus auritus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L) is a synthetic protein engineered to mimic the mitochondrial-encoded MT-ND4L subunit of Complex I in the electron transport chain. This recombinant variant is derived from the long-eared hedgehog (Hemiechinus auritus), a species native to arid deserts and steppes in Asia and North Africa . While MT-ND4L is typically encoded in mitochondrial DNA across eukaryotes, its recombinant form is produced in bacterial systems (e.g., E. coli) for structural, functional, and therapeutic research .

Production Workflow

StepDescriptionSource
Gene CloningMT-ND4L gene cloned into bacterial expression vectors (e.g., pET plasmids).
ExpressionInduced in E. coli under optimal growth conditions (e.g., 0.1–1 mM IPTG).
PurificationNickel-affinity chromatography for His-tagged proteins.
Quality ControlSDS-PAGE, Western blotting, and mass spectrometry for validation.

Applications

  • Structural Studies: Crystallization or cryo-EM to resolve MT-ND4L’s role in Complex I dynamics .

  • Disease Modeling: Investigating mutations linked to Leber hereditary optic neuropathy (LHON) or metabolic disorders .

  • Drug Discovery: Screening inhibitors or modulators targeting Complex I dysfunction .

Research Findings and Clinical Relevance

MT-ND4L Mutations and Disease
Mutations in MT-ND4L are implicated in Leber hereditary optic neuropathy (LHON), a mitochondrial disorder causing vision loss. For example:

  • T10663C Mutation: Replaces valine with alanine at position 65, disrupting Complex I activity and ATP production .

  • BMI and Metabolic Links: Variants in MT-ND4L correlate with obesity and hypertension in humans .

Therapeutic Potential
Recombinant MT-ND4L may aid in:

  • Gene Therapy: Replacing defective mitochondrial genes in LHON patients .

  • Small-Molecule Screens: Identifying compounds that restore Complex I function .

  • Protein Engineering: Designing variants to enhance quinone-binding efficiency .

Comparative Analysis of Recombinant MT-ND4L Proteins

SpeciesExpression SystemTagPurity (%)ApplicationsSource
Hemiechinus auritusE. coliN-terminal His>90Structural/biochemical studies
Oxymycterus rufusE. coliN-terminal His>90SDS-PAGE, Western blot
Pontoporia blainvilleiE. coliN-terminal His>90Enzyme activity assays

Challenges and Future Directions

  1. Limited Species-Specific Data: Most research focuses on human or model organisms; Hemiechinus auritus remains understudied .

  2. Mitochondrial Heteroplasmy: Challenges in achieving homoplasmic expression of recombinant MT-ND4L in vivo .

  3. Quinone-Binding Dynamics: Oversized ubiquinones reveal structural flexibility in Complex I’s quinone site .

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to pellet the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
MT-ND4L; MTND4L; NADH4L; ND4L; NADH-ubiquinone oxidoreductase chain 4L; NADH dehydrogenase subunit 4L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-98
Protein Length
full length protein
Species
Hemiechinus auritus (Long-eared hedgehog)
Target Names
Target Protein Sequence
MSIVYMNVMLAFMIALIGTLLYRHHLMSSLMCLEGMMLAMYIFISLISLNMHFTTMYMVP LIILVFAACEAALGLALLVKMFNYYGNDYVQNLNLLKC
Uniprot No.

Target Background

Function
A core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It catalyzes electron transfer from NADH through the respiratory chain, utilizing ubiquinone as the electron acceptor.
Protein Families
Complex I subunit 4L family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is MT-ND4L and what role does it play in mitochondrial function?

MT-ND4L is a small hydrophobic subunit of Complex I (NADH:ubiquinone oxidoreductase), the first enzyme of the mitochondrial respiratory chain. It functions as part of the machinery that catalyzes NADH oxidation by ubiquinone-10 (Q10), conserving energy through proton transport across the inner mitochondrial membrane . In Hemiechinus auritus (Long-eared hedgehog), MT-ND4L consists of 98 amino acids with multiple transmembrane segments that anchor it within the membrane .

Research has demonstrated that MT-ND4L is essential for proper Complex I assembly and function. Studies using RNA interference techniques have shown that the absence of ND4L prevents the assembly of the 950-kDa whole complex I and completely suppresses enzyme activity . This indicates that despite its small size, MT-ND4L plays a crucial structural role in maintaining the integrity of Complex I.

The protein contains several highly conserved regions that likely participate in protein-protein interactions with other Complex I subunits or contribute to the proton-pumping mechanism that drives ATP synthesis. As part of Complex I, MT-ND4L contributes to the first step of electron transport, which is fundamental to cellular energy production.

How does the amino acid sequence of Hemiechinus auritus MT-ND4L differ from other species?

The Hemiechinus auritus MT-ND4L protein consists of 98 amino acids with the sequence: MSIVYMNVMLAFMIALIGTLLYRHHIMSSIMCLEGMMLAMYIFISLISLNMHFTTMYMVPLIILVFAACEAALGLALLVKMFNYYGNDYVQNLNLLKC . This sequence reveals several key structural features characteristic of mitochondrial membrane proteins, including multiple hydrophobic regions that form transmembrane domains.

Nuclear-encoded ND4L proteins typically display reduced hydrophobicity compared to their mitochondrion-encoded counterparts, which facilitates their import into mitochondria following cytoplasmic synthesis . These differences provide valuable research opportunities for studying evolutionary adaptations in mitochondrial proteins following gene transfer events.

What experimental challenges are associated with working with recombinant MT-ND4L?

Working with recombinant MT-ND4L presents several significant technical challenges:

  • Extreme hydrophobicity: As a membrane protein with multiple transmembrane domains, MT-ND4L is highly hydrophobic, making it difficult to express, purify, and maintain in a functional state outside its native membrane environment .

  • Expression difficulties: The hydrophobic nature of MT-ND4L often leads to protein aggregation, misfolding, or toxicity to host cells during recombinant expression.

  • Purification complexities: Extracting and purifying MT-ND4L requires carefully optimized detergent conditions to solubilize the protein while maintaining its native structure and function.

  • Functional assessment: Evaluating the activity of recombinant MT-ND4L is challenging because it functions as part of a large multiprotein complex rather than as an individual enzyme.

  • Reconstitution requirements: For functional studies, MT-ND4L must be properly incorporated into a membrane environment, often requiring reconstitution into liposomes or other membrane-mimetic systems .

Researchers have developed specialized approaches to address these challenges, including the use of self-assembled proteoliposome systems containing various components of the respiratory chain to study complex I function in a controlled environment .

What expression systems are most suitable for producing functional recombinant MT-ND4L?

The selection of an appropriate expression system for recombinant MT-ND4L requires careful consideration of several factors. Based on research practices with similar mitochondrial membrane proteins, the following expression systems offer distinct advantages:

  • Bacterial expression systems:

    • E. coli strains engineered for membrane protein expression (C41(DE3), C43(DE3))

    • Expression as fusion proteins with solubility-enhancing tags (MBP, SUMO, Trx)

    • Controlled expression using tunable promoters and lower induction temperatures

  • Yeast expression systems:

    • Pichia pastoris or Saccharomyces cerevisiae provide eukaryotic processing machinery

    • Better suited for proper folding of eukaryotic membrane proteins

    • Can integrate expression constructs into the genome for stable production

  • Insect cell systems:

    • Baculovirus-infected insect cells offer enhanced membrane protein processing

    • Higher yields of correctly folded protein compared to bacterial systems

    • More sophisticated post-translational modification capabilities

  • Cell-free expression systems:

    • Allow direct incorporation into supplied lipid environments

    • Avoid toxicity issues associated with in vivo expression

    • Permit use of detergents or lipids during synthesis to enhance solubility

Each system requires optimization of expression conditions, including temperature, induction parameters, and media composition. For MT-ND4L specifically, codon optimization for the host organism and inclusion of appropriate purification tags that don't interfere with protein folding or function are particularly important considerations.

What purification strategies are most effective for isolating recombinant MT-ND4L?

Purifying recombinant MT-ND4L requires specialized approaches due to its hydrophobic nature and membrane localization. Effective purification strategies include:

Table 1: Comparison of Purification Methods for Recombinant MT-ND4L

MethodAdvantagesLimitationsOptimization Considerations
Affinity ChromatographySpecific capture of target proteinTag may affect structure/functionN- or C-terminal tag placement; cleavable tags
Size Exclusion ChromatographySeparation based on size; gentle conditionsLower resolutionBuffer composition; detergent selection
Ion Exchange ChromatographySeparates based on charge differencespH sensitivity may affect stabilitypH optimization; salt gradient parameters
Hydrophobic InteractionLeverages hydrophobicity of MT-ND4LMay require harsh elution conditionsSalt concentration; detergent compatibility

A typical purification protocol might include:

  • Membrane fraction isolation from expression host

  • Solubilization using carefully selected detergents (e.g., DDM, LMNG, or digitonin)

  • Initial capture using affinity chromatography (His-tag, FLAG-tag)

  • Secondary purification using size exclusion chromatography

  • Quality assessment using SDS-PAGE, Western blotting, and mass spectrometry

Throughout the purification process, maintaining an appropriate detergent concentration above the critical micelle concentration is essential to prevent protein aggregation. Additionally, inclusion of stabilizing agents such as glycerol or specific lipids may help preserve protein structure and function.

How can researchers verify the structural integrity and functionality of purified recombinant MT-ND4L?

Verifying that purified recombinant MT-ND4L maintains its native structure and function is critical for reliable experimental outcomes. Multiple complementary approaches should be employed:

  • Structural integrity assessment:

    • Circular dichroism (CD) spectroscopy to evaluate secondary structure content

    • Intrinsic fluorescence spectroscopy to assess tertiary structure

    • Limited proteolysis to evaluate proper folding

    • Mass spectrometry to confirm protein identity and post-translational modifications

  • Functional evaluation approaches:

    • Reconstitution into proteoliposomes with other Complex I components

    • NADH oxidation assays in reconstituted systems

    • Proton pumping assays using pH-sensitive dyes

    • Complementation studies in systems where endogenous MT-ND4L has been depleted

  • Interaction studies:

    • Pull-down assays with known interacting partners from Complex I

    • Blue native PAGE to assess incorporation into higher-order complexes

    • Cross-linking followed by mass spectrometry to identify interaction sites

Research has shown that absence of ND4L prevents proper assembly of the 950-kDa Complex I , so the ability of recombinant MT-ND4L to restore complex assembly in deficient systems provides a powerful functional verification method.

How can recombinant MT-ND4L be used to study Complex I assembly and function?

Recombinant MT-ND4L serves as a valuable tool for investigating several aspects of Complex I biology:

  • Assembly mechanism studies:

    • Complementation experiments in cells lacking endogenous MT-ND4L to study complex assembly

    • Time-course analysis of Complex I formation using tagged recombinant MT-ND4L

    • Identification of assembly intermediate complexes that depend on MT-ND4L incorporation

  • Structure-function investigations:

    • Site-directed mutagenesis of conserved residues to identify functionally important regions

    • Creation of chimeric proteins with MT-ND4L from different species to map functional domains

    • Introduction of disease-associated mutations to study pathological mechanisms

  • Interaction mapping:

    • Identification of direct binding partners within Complex I

    • Characterization of interfaces between MT-ND4L and other subunits

    • Investigation of how MT-ND4L contributes to the stability of the entire complex

Research has demonstrated that the absence of ND4L prevents assembly of the 950-kDa whole Complex I and suppresses enzyme activity , highlighting the essential role of this small subunit in complex integrity. By manipulating recombinant MT-ND4L through mutation or domain swapping, researchers can systematically probe its contribution to Complex I structure and function.

A significant advantage of using recombinant protein is the ability to incorporate specific modifications, such as fluorescent tags or crosslinking sites, which facilitate detailed mechanistic studies that would not be possible with endogenous protein.

What approaches can be used to study the interaction between MT-ND4L and other Complex I subunits?

Understanding the interactions between MT-ND4L and other Complex I components is crucial for elucidating the assembly and function of this essential respiratory enzyme. Several complementary approaches can be employed:

  • Biochemical interaction methods:

    • Chemical cross-linking followed by mass spectrometry

    • Co-immunoprecipitation with antibodies against MT-ND4L or potential partners

    • Proximity labeling techniques (BioID, APEX) to identify neighboring proteins

    • Surface plasmon resonance to measure binding kinetics with purified components

  • Biophysical approaches:

    • Förster resonance energy transfer (FRET) between fluorescently labeled subunits

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

    • Electron paramagnetic resonance (EPR) spectroscopy with spin-labeled proteins

    • Nuclear magnetic resonance (NMR) of specific domains or peptides

  • Functional interaction studies:

    • Suppressor mutation analysis to identify compensatory changes in interacting subunits

    • Second-site reversion studies following MT-ND4L mutation

    • Activity assays with reconstituted subcomplexes containing MT-ND4L variants

Using combinations of these approaches can provide comprehensive insights into how MT-ND4L interacts with other Complex I components. For example, research has shown that the absence of ND4L prevents proper assembly of Complex I , suggesting it forms critical interactions necessary for complex formation and stability.

How does MT-ND4L contribute to the proton-pumping mechanism of Complex I?

The precise role of MT-ND4L in the proton-pumping function of Complex I remains an active area of investigation. Current research suggests several possible mechanisms:

  • Direct proton channel involvement:

    • MT-ND4L may form part of a proton translocation pathway through Complex I

    • Conserved charged or protonatable residues might participate in proton transfer

    • Specific transmembrane domains may create water-filled channels for proton movement

  • Conformational coupling:

    • MT-ND4L could transduce conformational changes that couple electron transfer to proton pumping

    • Strategic positioning between functional domains may allow energy transmission

    • Interaction with mobile elements of Complex I during catalytic cycles

  • Structural support:

    • Proper positioning of key proton-pumping components depends on MT-ND4L structure

    • Maintenance of critical distances between functional elements

    • Stabilization of conformational states necessary for proton translocation

Research approaches to investigate these possibilities include site-directed mutagenesis of conserved residues, proton pumping assays in reconstituted systems, and computational modeling of proton transfer pathways. The self-assembled respiratory chain system described in previous research provides a controlled environment for studying these mechanisms by incorporating recombinant components into proteoliposomes.

Complex I conserves energy from NADH oxidation by ubiquinone-10 (Q10) in proton transport across a membrane , and understanding MT-ND4L's contribution to this process is essential for developing a complete model of mitochondrial energy conversion.

How has the genomic location of ND4L evolved across species and what are the functional implications?

The genomic location of the ND4L gene showcases a fascinating example of evolutionary plasticity in mitochondrial components. While typically encoded in the mitochondrial genome (MT-ND4L), in some species, this gene has been transferred to the nuclear genome:

  • Mitochondrial encoding (most species):

    • In Hemiechinus auritus and most other mammals, MT-ND4L is encoded in the mitochondrial genome

    • This represents the ancestral state for this gene

    • Allows co-regulation with other mitochondrially-encoded Complex I components

    • Results in highly hydrophobic protein synthesized within the mitochondria

  • Nuclear encoding (select species):

    • In Chlamydomonas reinhardtii, ND4L is encoded by the nuclear gene NUO11

    • Represents a relatively rare evolutionary gene transfer event

    • Necessitates development of mitochondrial targeting mechanisms

    • Results in modifications to protein properties to facilitate import

The functional implications of this genomic relocation are significant:

  • Protein structural adaptations:

    • Nuclear-encoded ND4L shows reduced hydrophobicity compared to mitochondrion-encoded counterparts

    • Modifications facilitate protein import across mitochondrial membranes

    • Nevertheless, the protein must maintain its core functional properties for Complex I assembly

  • Regulatory differences:

    • Nuclear genes are subject to different transcriptional control mechanisms

    • Allows integration of ND4L expression with nuclear-encoded mitochondrial proteins

    • May provide advantages in coordinating nuclear and mitochondrial gene expression

This evolutionary transition provides valuable research opportunities for understanding mitochondrial gene transfer mechanisms and the adaptations that facilitate successful relocation of essential respiratory chain components.

How can comparative studies of MT-ND4L from different species inform our understanding of mitochondrial disease mechanisms?

Comparative analysis of MT-ND4L across species provides valuable insights into both normal function and disease mechanisms:

  • Identification of conserved functional elements:

    • Residues or domains conserved across diverse species likely represent critical functional regions

    • Mutations in these conserved elements are more likely to cause disease

    • Evolutionary conservation patterns can highlight residues essential for protein-protein interactions or catalytic function

  • Natural experiments in protein modification:

    • Species with nuclear-encoded ND4L (like Chlamydomonas) demonstrate compatible structural modifications

    • These natural variants reveal which protein features are adaptable versus essential

    • Understanding this flexibility helps predict the impact of human mutations

  • Disease mechanism insights:

    • Comparison of human disease mutations with naturally occurring variations in other species

    • Identification of compensatory mechanisms in species that tolerate sequence changes

    • Development of model systems that recapitulate human disease-causing mutations

  • Therapeutic development opportunities:

    • Cross-species functional studies can identify potential routes for therapeutic intervention

    • Alternative protein forms that maintain function despite structural differences

    • Naturally evolved solutions to protein stability or assembly challenges

Mutations in MT-ND4L have been associated with mitochondrial disorders, including Leigh syndrome and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). Understanding how these mutations disrupt protein function in the context of evolutionary conservation patterns can provide crucial insights into pathological mechanisms and potential therapeutic strategies.

What controls are essential when studying recombinant MT-ND4L activity in reconstituted systems?

Proper experimental controls are critical for reliable interpretation of results when working with recombinant MT-ND4L:

Table 2: Essential Controls for MT-ND4L Functional Studies

Control TypeExamplePurposeImplementation
Negative ControlsSystems lacking MT-ND4LEstablish baseline activityCompare complete system to one with MT-ND4L omitted
Inactive MT-ND4L mutantsVerify specificity of observed effectsIntroduce mutations in conserved residues
Complex I inhibitors (e.g., rotenone)Confirm assay specificityAdd specific inhibitors to functional assays
Positive ControlsNative Complex I preparationsBenchmark for activity comparisonIsolate native Complex I from relevant tissues
Well-characterized recombinant systemsValidate experimental approachUse previously published functional systems
Quality ControlsProtein purity verificationEnsure absence of contaminating proteinsMultiple purification steps; analytical techniques
Structural integrity assessmentConfirm proper protein foldingSpectroscopic methods (CD, fluorescence)
Membrane incorporation verificationEnsure proper lipid environmentFlotation assays; protease protection
Specificity ControlsDose-response relationshipsEstablish quantitative functional relationshipsVary MT-ND4L concentration in reconstituted systems
Recovery experimentsDemonstrate reversibility of effectsRescue MT-ND4L depletion with recombinant protein

The self-assembled system described in previous research represents an excellent example of proper experimental design, where the alternative oxidase (AOX) is present in excess so that Complex I becomes completely rate-determining, allowing precise measurement of its activity .

When interpreting experimental results, researchers should consider how the choice of detergents, lipids, and other components in reconstituted systems might influence MT-ND4L function, as these factors can significantly impact the behavior of membrane proteins.

How can researchers resolve common technical issues when working with recombinant MT-ND4L?

Working with recombinant MT-ND4L presents several technical challenges. The following troubleshooting guidance addresses common issues:

  • Low expression yields:

    • Problem: Poor protein expression due to toxicity or protein instability

    • Solutions:

      • Use lower induction temperatures (16-20°C) to slow expression and improve folding

      • Try specialized expression strains designed for membrane proteins

      • Express as fusion with solubility-enhancing tags (MBP, SUMO)

      • Optimize codon usage for expression host

      • Consider cell-free expression systems for highly toxic proteins

  • Protein aggregation during purification:

    • Problem: Formation of inclusion bodies or aggregates

    • Solutions:

      • Optimize detergent selection and concentration

      • Include stabilizing agents like glycerol or specific lipids

      • Test various solubilization conditions (pH, salt concentration)

      • Consider on-column refolding approaches

      • Explore mild solubilization using styrene maleic acid lipid particles (SMALPs)

  • Poor incorporation into liposomes:

    • Problem: Inefficient reconstitution into membrane systems

    • Solutions:

      • Optimize protein:lipid ratios

      • Test different lipid compositions to better mimic native environment

      • Use detergent removal methods compatible with MT-ND4L stability

      • Consider direct incorporation during protein synthesis in cell-free systems

      • Explore nanodisc technology for single-protein studies

  • Low or absent activity in functional assays:

    • Problem: Recombinant protein lacks expected activity

    • Solutions:

      • Verify structural integrity before functional testing

      • Ensure all necessary Complex I components are present

      • Check for inhibitory contaminants in the preparation

      • Optimize buffer conditions (pH, ionic strength)

      • Consider that additional factors might be required for activity

These troubleshooting approaches are particularly relevant when working with highly hydrophobic proteins like MT-ND4L, where maintaining the native structure during recombinant expression and purification represents a significant challenge.

What emerging technologies might advance our understanding of MT-ND4L's role in Complex I function?

Several cutting-edge technologies hold promise for deepening our understanding of MT-ND4L's role in Complex I:

  • Advanced structural biology techniques:

    • High-resolution cryo-electron microscopy to visualize MT-ND4L within intact Complex I

    • Time-resolved structural studies to capture conformational changes during catalysis

    • Integrative structural biology approaches combining multiple data sources

  • Single-molecule methodologies:

    • FRET-based approaches to monitor protein dynamics during electron transfer

    • Nanodisk technologies to study individual Complex I molecules

    • High-speed atomic force microscopy to observe structural changes in real-time

  • Synthetic biology approaches:

    • Bottom-up construction of minimal respiratory systems with defined components

    • Development of simplified model systems to isolate specific functional aspects

    • Creation of hybrid complexes with components from different species

  • Advanced genetic tools:

    • CRISPR-based approaches for precise manipulation of MT-ND4L in various model systems

    • Rapid mutagenesis platforms for comprehensive structure-function mapping

    • Orthogonal translation systems for incorporation of non-canonical amino acids

  • Computational advances:

    • Molecular dynamics simulations of MT-ND4L within complex I

    • Quantum mechanics/molecular mechanics (QM/MM) calculations of electron transfer

    • Machine learning approaches to predict effects of mutations or drug interactions

The integration of these technologies promises to overcome current limitations in studying this challenging but essential mitochondrial protein. The self-assembled respiratory chain system described in previous research represents an example of innovative approaches that can circumvent traditional experimental limitations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.